buprenorphine transdermal system
NDC 47781-407, buprenorphine, patch, extended release, from Alvogen Inc..
- Product NDC
- 47781-407
- Status
- Listed
- Labeler
- Alvogen Inc.
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207490
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/47781-407 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE10 ug/h
Pharmacologic classes
Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 47781-407-04 | 47781040704 | 4 POUCH in 1 CARTON (47781-407-04) / 1 PATCH in 1 POUCH (47781-407-11) / 168 h in 1 PATCH |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/315284b8-32ab-d34a-ea02-f501c6131bcc
Use it
Look up 47781-407 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/47781-407 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 47781-407. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.